EP2999711
Fjölmýxínafleiður og notkun þeirra í samsetta meðferð ásamt mismunandi sýklalyfjum
:
EP einkaleyfi í gildi á Íslandi:
21.5.2014:
29.6.2022:
14726731.4
:
8.8.2022:
15.9.2022
:
20.5.2034:
20.5.2026:
31.5.2026
:
POLYMYXIN DERIVATIVES AND THEIR USE IN COMBINATION THERAPY TOGETHER WITH DIFFERENT ANTIBIOTICS
21.5.2014
29.6.2022
8.8.2022
15.9.2022
20.5.2026
:
Spero Therapeutics, Inc.:
675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139, US
:
BROWN, Pamela:
Reading Berkshire RG1 8LS, GB
:
DAWSON, Michael:
Reading Berkshire RG1 8LS, GB
:
SIMONOVIC, Mona:
Reading Berkshire RG1 8LS, GB
:
BOAKES, Steven:
Reading Berkshire RG1 8LS, GB
:
DUPERCHY, Esther:
Reading Berkshire RG1 8LS, GB
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201309248:
22.5.2013:
GB
:
201404301:
11.3.2014:
GB
:
GB2014051547:
21.5.2014
:
C07K 7/62, A61K 38/12
: 10
: 2.3.2023
: 20.5.2024
: Árnason Faktor ehf.
: 11
: 12.4.2024
: 20.5.2025
: Árnason Faktor ehf.
: 12
: 5.5.2025
: 20.5.2026
: Árnason Faktor ehf.